NCT06829420 Mirror Speech Entrainment: A Novel Technique for Voice Personalized Speech Entrainment for Nonfluent Aphasia
| NCT ID | NCT06829420 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Florida |
| Condition | Aphasia Non Fluent |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-05-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to improve language production of persons with aphasia (PWA). The main question the study aims to answer is: \- What is the impact of personalized voice on speech entrainment in PWA compared to traditional speech entrainment? Speech entrainment is a technique used by speech-language pathologists to improve the speech production of PWA. Traditionally, speech therapists act as the model for participants to speak along with to improve their speech production. This study proposes the use of one's own voice (digitally altered) to improve speech production. The study uses a mobile health approach to administer speech entrainment treatment through a mobile app. * Smartphones with the mobile app pre-installed will be mailed to participants at no cost. * Participants will complete treatment in the comfort of their homes. * The experimental treatments involve: mirror speech entrainment (speaking along to one's own voice) and traditional speech entrainment (speaking along to someone else's voice).
Eligibility Criteria
Inclusion Criteria: * Adults between the ages of 18-70 years old * Dominant English-speaking * Aphasia due to left hemisphere stroke Exclusion Criteria: * Individuals with aphasia due to other causes such as dementia, Alzheimer's disease and Parkinsonism * Non-dominant English adult speakers * Persons with significant difficulties with language comprehension * Persons with concomitant cognitive disability * Persons with uncorrected sensory deficits.
Frequently Asked Questions
Who can join the NCT06829420 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Aphasia Non Fluent. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06829420 currently recruiting?
Yes, NCT06829420 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of South Florida to inquire about joining.
Where is the NCT06829420 trial being conducted?
This trial is being conducted at Tampa, United States, Tampa, United States.
Who is sponsoring the NCT06829420 clinical trial?
NCT06829420 is sponsored by University of South Florida. The trial plans to enroll 20 participants.